Overview

RNA Empire examines the transformation of RNA from a molecular intermediary into one of the most powerful therapeutic platforms in modern biotechnology. From messenger RNA vaccines to gene silencing technologies, aptamers, circular RNA, and the convergence of CRISPR with RNA systems, this volume explores how RNA became programmable infrastructure. It analyzes the scientific breakthroughs that made RNA medicines possible, the delivery systems that enabled clinical translation, and the platform strategies that turned RNA into a scalable enterprise. Rather than presenting RNA as a single technological wave, this book frames it as an ecosystem - where molecular engineering, lipid nanoparticle delivery, manufacturing scalability, regulatory navigation, and funding strategy determine long-term dominance. Written for scientists, translational researchers, founders, and biotech strategists, RNA Empire connects mechanism with monetization and discovery with durable platform building. Who This Book Is ForThis volume is written for graduate students, postdoctoral researchers, clinician-scientists, RNA biologists, biotech founders, translational teams, and innovation-driven institutions seeking a rigorous understanding of RNA platform strategy. It is also appropriate for academic libraries and biotechnology incubators focused on next-generation therapeutics. Table of ContentsPart I - The Science of RNA Chapter 1 - RNA: The Unsung Architect of Life Chapter 2 - The RNA Toolbox Chapter 3 - How mRNA Became a Medicine Part II - RNA Therapeutics Chapter 4 - RNA Delivery Systems Chapter 5 - mRNA Therapeutics: Vaccines & Beyond Chapter 6 - mRNA Interference & Gene Silencing Chapter 7 - Aptamers: The Nucleic-Acid Antibodies Chapter 8 - CRISPR Meets RNA Chapter 9 - Cell-Free RNA Manufacturing Chapter 10- Circular RNA & Next-Gen RNA Drugs Part III - RNA Industry Chapter 11 - RNA-Based Therapeutic Platforms Chapter 12 - BioLionaire Roadmap in the RNA Age Appendices Appendix A - NIH SBIR Phase I Proposal Roadmap Appendix B - Example (II) SBIR Phase I Grant Proposal Glossary Index Companies Discussed in this Volume Essential Reading

Full Product Details

9798244494228

Table of Contents

Reviews

Author Information

Tab Content 6

Countries Available